Category: 3. Business

  • Rio Tinto releases third quarter 2025 production results

    Our pace continues – strong production across the portfolio

    MELBOURNE, Australia–(BUSINESS WIRE)–
    Rio Tinto Chief Executive Simon Trott said: “Safety remains our number one priority. We are deeply saddened by the tragic death of Mohamed Camara at the SimFer mine site and are committed to learning across our business to prevent future incidents. This has been a time for huge reflections on safety across the group.

    “We continue to strengthen performance from our assets, setting back-to-back quarterly production records in our bauxite business and at Oyu Tolgoi – where the underground ramp-up remains on track to boost copper output by more than 50% this year.

    “We are focused on delivering a strong finish to the year from the Pilbara. Our growth projects are also progressing at pace – at Simandou, we started loading first ore at the mine for movement down the rail and to the port in October.

    “We are on track to meet production guidance for 2025, with an upwards revision to bauxite this quarter, and are well positioned to deliver compelling mid-term production growth. We will continue to deliver further shareholder value through operational excellence, simplification and discipline on performance and capital investment.”

    Executive Summary

    • New operating model and executive team: to simplify the business and unlock additional shareholder value. New structure comprises three world-class businesses: Iron Ore; Aluminium & Lithium; and Copper. Borates and Iron & Titanium have been placed under strategic review.

    • Copper equivalent (CuEq)1 production: increased 9% in Q3 YoY, driven by strong performance across all our assets.

    • Copper: Total production is on track to achieve the higher end of full year guidance, driven by the strong ramp-up at Oyu Tolgoi. Our Kennecott mine performed as expected during the quarter while major planned maintenance at the concentrator and smelter commenced successfully.

    • Iron ore: Pilbara achieved its second highest Q3 shipments since 2019, up 6% from Q2. As part of our Iron Ore replacement strategy, West Angelas Sustaining Project received all Government approvals in October.

    • Aluminium & Lithium: Full year bauxite production guidance upgraded driven by operational excellence at our bauxite business, especially at Amrun.

    Production2

     

    Quarter 3

    2025

    vs Q3

    2024

    vs Q2

    2025

    2025 guidance6

    Guidance status

    Pilbara iron ore shipments (100% basis)

    Mt

    84.3

    –%

    +6%

    323 to 338

    (at lower end)

    Unchanged

    Pilbara iron ore production (100% basis)

    Mt

    84.1

    –%

    –%

    NA

    Unchanged

    IOC5 iron ore pellets and concentrate

    Mt

    2.3

    +11%

    -6%

    9.7 to 11.4

    Unchanged

    (at lower end)

    Bauxite

    Mt

    16.4

    +9%

    +5%

    59 to 61

    (previously 57 to 59)

    Upgraded

    Alumina

    Mt

    1.9

    +7%

    +4%

    7.4 to 7.8

    Unchanged

    Aluminium3

    Mt

    0.86

    +6%

    +2%

    3.25 to 3.45

    Unchanged

    Copper (consolidated basis)4

    kt

    204

    +10%

    -11%

    780 to 850

    (at higher end)

    Unchanged

    Titanium dioxide slag

    Mt

    0.3

    -1%

    -3%

    1.0 to 1.2

    (at lower end)

    Unchanged

    Boric oxide equivalent

    Mt

    0.1

    +2%

    -3%

    ~0.5

    Unchanged

    1 Copper equivalent volume = Rio Tinto’s share of production volume / Volume conversion factor x Product price ($/t) / Copper price ($/t). Prices are based on long-term consensus prices.2 Rio Tinto share unless otherwise stated.3 Includes primary aluminium only.4 From Q1 2025, we report copper production and guidance as one metric, in order to simplify reporting and align with peer practices. For further details see slide 90 of our Investor Seminar 2024 presentation.5 Iron Ore Company of Canada.6 See further notes in Section 2, 2025 guidance.

     

    The full third quarter production results are available here

    This announcement is authorised for release to the market by Andy Hodges, Rio Tinto’s Group Company Secretary.

    LEI: 213800YOEO5OQ72G2R82

    Classification: 3.1 Additional regulated information required to be disclosed under the laws of a Member State

    Please direct all enquiries to media.enquiries@riotinto.com

    Media Relations,

    United Kingdom

    Matthew Klar

    M +44 7796 630 637

    David Outhwaite

    M +44 7787 597 493

    Media Relations,

    Australia

    Matt Chambers

    M +61 433 525 739

    Rachel Pupazzoni

    M +61 438 875 469

    Bruce Tobin

    M +61 419 103 454

    Media Relations,

    Canada

    Simon Letendre

    M +1 514 796 4973

    Malika Cherry

    M +1 418 592 7293

    Vanessa Damha

    M +1 514 715 2152

    Media Relations,

    U
    S & Latin America

    Jesse Riseborough

    M +1 202 394 9480

    Investor Relations,

    United Kingdom

    Rachel Arellano

    M:
    +44 7584 609 644

    David Ovington

    M +44 7920 010 978

    Laura Brooks

    M +44 7826 942 797

    Weiwei Hu

    M +44 7825 907 230

    Investor Relations,

    Australia

    Tom Gallop

    M +61 439 353 948

    Phoebe Lee

    M +61 413 557 780

    Rio Tinto plc

    6 St James’s Square

    London SW1Y 4AD

    United Kingdom

    T +44 20 7781 2000

    Registered in England

    No. 719885

    Rio Tinto Limited

    Level 43, 120 Collins Street

    Melbourne 3000

    Australia

    T +61 3 9283 3333

    Registered in Australia

    ABN 96 004 458 404

    riotinto.com

    Category: General

    Source: Rio Tinto


    Continue Reading

  • Gen Z staff lead workplace AI adoption despite job fears – Microsoft Australia study – Microsoft Source

    1. Gen Z staff lead workplace AI adoption despite job fears – Microsoft Australia study  Microsoft Source
    2. Young Aussies drive AI adoption despite job security fears  SecurityBrief Australia
    3. Young Aussie workers fear AI but use it to get ahead  inkl
    4. Gen Z Engages with AI More Than Their Managers  Facilitiesnet

    Continue Reading

  • After record crypto crash, a rush to hedge against another freefall – Reuters

    1. After record crypto crash, a rush to hedge against another freefall  Reuters
    2. Bitcoin, Ethereum, XRP Jump After Crypto Crash. What’s Fueling the Rebound.  Barron’s
    3. Crypto bloodbath wipes out billions, but signs of stabilization emerge  Fox Business
    4. Trump Tariffs Upend Crypto Market, Trigger Record Liquidations  Bloomberg.com
    5. $19.4B Liquidated: Is the Bull Market Finally Over?  Binance

    Continue Reading

  • Tesla Stock Rises. Why It's Rallying After Trump's China Trade Scare. – Barron's

    1. Tesla Stock Rises. Why It’s Rallying After Trump’s China Trade Scare.  Barron’s
    2. Tesla Stock a Must Own Though Valuation a Guesswork, Melius Says  Bloomberg.com
    3. Tesla (NASDAQ:TSLA) Now Covered by Analysts at Melius  MarketBeat
    4. This Analyst Is Already Counting Optimus for 6% of Tesla’s Price Target. What Does That Mean for TSLA Stock?  Barchart.com
    5. Tesla price target raised to $300 from $235 at Evercore ISI  TipRanks

    Continue Reading

  • Bombardier Global 8000, The World’s Fastest Business Jet, Gets Even Faster with a New Top Speed of Mach 0.95

    Bombardier Global 8000, The World’s Fastest Business Jet, Gets Even Faster with a New Top Speed of Mach 0.95

    • The Bombardier Global 8000(1) is on track to enter service in 2025 as the fastest civil aircraft since the Concorde and it will set a new industry benchmark with a MMO of Mach 0.95
    • Bombardier’s Global 8000 aircraft features a best-in-class range of 8,000 NM, unmatched landing performance and the smoothest ride
    • First Global 8000 production aircraft completed a seamless inaugural flight in May and is currently wrapping up interior completions in parallel to final type certification activities

    Bombardier today announced that the Global 8000, the world’s fastest business jet, just got faster with a new top speed of Mach 0.95 (2) – the highest speed in civil aviation and the fastest business jet in history. The ultra-long-range Global 8000 aircraft will be able to fly clients to their desired destinations even faster and feeling refreshed and ready to go. This new development in the Global 8000 aircraft’s road toward entry into service was announced as part of the 2025 edition of the NBAA Business Aviation Convention and Exhibition in Las Vegas. 

    “This accomplishment for Bombardier is reflective of the remarkable expertise of every employee that has worked on the development of this industry-leading business jet,” said Éric Martel, President and CEO, Bombardier. “With our Bombardier Global 8000, our customers will now be able to reach their destinations even faster, arriving refreshed and ready to carry out their desired missions.”

    “The Global 8000 was already the fastest business aircraft ever built, and with this new speed capability, this incredible aircraft is set to redefine the ultra-long-range market,” said Stephen McCullough, Senior Vice President, Engineering and Product Development, Bombardier. “This achievement underscores the significant contributions of our innovative design, flight test and production teams and showcases their immense expertise, obsession with excellence and unrelenting commitment to push the boundaries – the heartbeat that drives everything we do at Bombardier.”

    In addition to its incredible speed, the Bombardier Global 8000 is also nimble and provides the smoothest ride. It possesses class-leading runway performance comparable to that of a light jet. Its unique wing design featuring leading-edge slats enables customers to access up to 30% more airports than its closest rival. 

    The Global 8000 aircraft will also set an extremely high bar in terms of cabin comfort and technology. This trailblazing business jet will feature four true living spaces and a separate crew rest area. It will also feature the longest seated length in its class along with the industry’s healthiest cabin with ultra-low cabin altitude, designed to maximize passenger comfort and productivity throughout their travels. The Global 8000 business jet is the clear choice for discerning owners and operators seeking the ultimate time machine – the fastest time machine in the skies.

    About Bombardier

    At Bombardier (BBD-B.TO), we design, build, modify and maintain the world’s best-performing aircraft for the world’s most discerning people and businesses, governments and militaries. That means not simply exceeding standards, but understanding customers well enough to anticipate their unspoken needs.

    For them, we are committed to pioneering the future of aviation—innovating to make flying more reliable, efficient and sustainable. And we are passionate about delivering unrivaled craftsmanship and care, giving our customers greater confidence and the elevated experience they deserve and expect. Because people who shape the world will always need the most productive and responsible ways to move through it.

    Bombardier customers operate a fleet of more than 5,100 aircraft, supported by a vast network of Bombardier team members worldwide and 10 service facilities across six countries.

    Bombardier’s performance-leading jets are proudly manufactured in aerostructure, assembly and completion facilities in Canada, the United States and Mexico. In 2024, Bombardier was honoured with the prestigious “Red Dot: Best of the Best” award for Brands and Communication Design.     

    For Information

    For corporate news and information, including Bombardier’s Sustainability report, as well as the company’s initiative to cover all its flight operations with a Sustainable Aviation Fuel (SAF) blend utilizing the Book-and-Claim system visit
    bombardier.com.

    Learn more about Bombardier’s industry-leading products and customer service network at bombardier.com. Follow us on X @Bombardier.

    Media Contacts

    General media contact webform

    Matthew Nicholls
    +1-514-243-8214
    Matthew.Nicholls@aero.bombardier.com

    (1)The Global 8000 aircraft is currently under development and remains to be finalized and certified. All specifications and data are approximate, may change without notice and are subject to certain operating rules, assumptions and other conditions. It is expected to enter service in 2025. Please also see the forward-looking statements disclaimer at the end of this press release

    (2)All specifications and data are approximate, may change without notice and are subject to certain operating rules, assumptions and other conditions. The Global 8000 is expected to enter service in 2025. Please also see the forward-looking statements disclaimer at the end of this press release

    Bombardier, Global, and Global 8000 are registered or unregistered trademarks of Bombardier Inc. or its subsidiaries

    Forward-looking statements
    This press release contains certain forward-looking statements. By their nature, forward-looking statements require the Corporation to make assumptions and are subject to important known and unknown risks and uncertainties, which may cause actual results in future periods to differ materially from those set forth in the forward-looking statements. Please refer to the “Forward-Looking Statements” disclaimer contained in Bombardier Inc.’s most recently published financial report for additional details.

    Continue Reading

  • Continuous Liquidity Essential To ‘Prudent Risk Management’

    Continuous Liquidity Essential To ‘Prudent Risk Management’

    Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.

    Bitcoin’s (CRYPTO: BTC) flash crash late Friday, which happened outside of regular trading hours, has reignited debate about the operating hours of spot BTC exchange-traded funds, particularly the iShares Bitcoin Trust ETF (NASDAQ:IBIT).

    The apex cryptocurrency collapsed from $116,000 to under $110,000 within minutes after President Donald Trump threatened 100% tariffs on China in response to “aggressive stance” on export controls.

    The sudden spike caught traders off-guard, triggering over $19 billion in liquidations, the largest single-day wipeout in cryptocurrency history.”

    Trending: Missed Nvidia and Tesla? RAD Intel Could Be the Next AI Powerhouse — Just $0.81 a Share

    The crash fueled concerns about the lack of 24/7 trading of BTC exchange-traded funds, which have become a popular vehicle for institutional investors, Forbes reported, quoting Tommy Doyle, global head of client management at Xapo Bank.

    “The extreme volatility in the price of Bitcoin overnight highlights why institutional investors increasingly view access to 24/7 liquidity as essential to prudent risk management,” Doyle said.

    Notably, these ETFs, including the nearly $100 billion IBIT, are bound by stock trading hours, which prevents investors from responding to weekend price shifts.

    “Whilst Bitcoin ETFs remain bound by traditional market trading hours, institutional investors with direct bitcoin accounts can continue to access liquidity and risk manage their bitcoin exposure throughout the weekend, especially relevant amid recent seismic price moves,” Doyle told Forbes.

    See Also: Accredited Investors Can Now Tap Into the $36 Trillion Home Equity Market — Without Buying a Single Property

    It’s worth noting that Robinhood allows trading from 8 p.m. ET on Sunday until 8 p.m. ET on Friday, with some restrictions.

    BlackRock’s IBIT ETF is the largest cryptocurrency-based investment fund currently in operation, with assets under management totaling almost $94 billion, according to SoSo Value.

    Overall, BTC ETFs reported net inflows exceeding $2.70 billion for the week ended Oct.10.

    Photo Courtesy: Arsenii Palivoda on Shutterstock.com

    Trending Now:

    Continue Reading

  • Traders eye the 20-day moving average on the S&P 500 as a critical level for the mar

    Traders eye the 20-day moving average on the S&P 500 as a critical level for the mar

    Continue Reading

  • Fruquintinib Combo Prolongs PFS in Advanced/Metastatic RCC

    Fruquintinib Combo Prolongs PFS in Advanced/Metastatic RCC

    Combining fruquintinib (Fruzaqla) with sintilimab (Tyvyt) significantly improved progression-free survival (PFS) vs axitinib (Inlyta) or everolimus (Afinitor) monotherapy among patients with locally advanced or metastatic renal cell carcinoma (RCC), according to a press release on findings from the phase 2/3 FRUSICA-2 trial (NCT05522231).1

    With a median follow-up of 16.6 months and a cutoff date of February 17, 2025, data from the phase 3 portion of the trial revealed a median PFS of 22.2 months in the fruquintinib arm and 6.9 months in the comparator arm (stratified HR, 0.373; P <.0001). Additionally, the objective response rate (ORR) was 60.5% vs 24.3% (OR, 4.622; P <.0001), with a median duration of response (DOR) of 23.7 months and 11.3 months in each arm.

    Data related to overall survival (OS) were still maturing at the time of analysis. Investigators noted efficacy benefits with the fruquintinib combination across all prognostic risk subgroups based on the International mRCC Database Consortium (IMDC) guidelines.

    Treatment with fruquintinib plus sintilimab appeared to be tolerable and comparable with prior reports of each agent. Grade 3 or higher treatment-emergent adverse effects (TEAEs) occurred in 71.4% of the experimental arm and 58.8% of the comparator arm.

    Investigators will present detailed results from the FRUSICA-2 trial at the 2025 European Society for Medical Oncology (ESMO) Congress.

    “The FRUSICA-2 trial results provide compelling evidence that fruquintinib and sintilimab may offer a valuable new treatment option for patients with advanced [RCC],” co-leading principal trial investigator Dingwei Ye, MD, PhD, a professor at Fudan University Shanghai Cancer Center, stated in the press release.1 “These findings show the combination’s potential to address a critical unmet need for this patient population, delivering consistent benefits across varied patient profiles and prognostic risk groups.”

    According to the press release, China’s National Medical Products Administration is currently reviewing a new drug application for fruquintinib plus sintilimab as a treatment for those with previously treated metastatic or locally advanced RCC based on data from the FRUSCIA-2 trial.

    Investigators of the open-label, active-controlled, registration FRUSICA-2 trial assessed the safety and efficacy of fruquintinib plus sintilimab vs monotherapy with axitinib or everolimus among 234 patients with second-line advanced RCC. In the combination arm, patients received fruquintinib at 5 mg orally each day in a 2-week-on, 1-week-off schedule every 3 weeks per cycle plus sintilimab at 200 mg intravenously every 3 weeks.2

    The trial’s primary end points included PFS in part 1 and ORR in part 2. Secondary end points included the disease control rate, DOR, time to response, OS, safety, and quality of life.

    Patients 18 to 75 years old with histologically or cytologically confirmed RCC, locally advanced or metastatic disease, and progression on or after prior frontline treatment with a VEGF-directed tyrosine kinase inhibitor were eligible for enrollment on the trial. Other eligibility criteria included having at least 1 measurable lesion per RECIST v1.1 guidelines, an ECOG performance status of 0 or 1, and adequate organ function.

    Those with prior receipt of approved systemic anti-cancer therapy within 2 weeks of beginning study treatment, active autoimmune or inflammatory diseases, or known central nervous system metastases were ineligible to enroll on the trial. Patients were also unsuitable for study entry if they had a history of pneumonitis requiring corticosteroid therapy, a history of or current interstitial lung disease, or current active pulmonary infection.

    “The FRUSICA-2 study suggests that fruquintinib and sintilimab could play a meaningful role in shaping second-line treatment strategies for advanced [RCC],” co-leading principal investigator Zhisong He, a professor at Peking University First Hospital, said in the press release.1 “These results point to the combination’s potential to enhance clinical outcomes, providing a new option for managing this challenging disease.”

    References

    1. HUTCHMED highlights FRUSICA-2 registration trial data to be presented at the 2025 ESMO Congress. News release. HUTCHMED Limited. October 13, 2025. Accessed October 13, 2025. https://tinyurl.com/3h8ycmxm
    2. Efficacy and safety of fruquintinib in combination with sintilimab in advanced renal cell carcinoma (FRUSICA-2). ClinicalTrials.gov. Updated January 3, 2025. Accessed October 13, 2025. https://tinyurl.com/d5s5mtjb

    Continue Reading

  • Investors should brace for more trade-war volatility as 'high-stakes game of chicken' between U.S. and China begins – Morningstar

    1. Investors should brace for more trade-war volatility as ‘high-stakes game of chicken’ between U.S. and China begins  Morningstar
    2. China accuses US of ‘double standards’ over tariff threat  BBC
    3. Dow gains almost 600 points after US-China trade showdown hits the pause button  CNN
    4. Wall Street ends sharply higher on Trump China comments; Broadcom surges  Reuters
    5. Beijing blames US for raising trade tensions, defends rare earth curbs  Dawn

    Continue Reading

  • HEPA purifiers not tied to less viral exposure in elementary classrooms, analysis finds

    HEPA purifiers not tied to less viral exposure in elementary classrooms, analysis finds

    A secondary analysis of a randomized clinical trial of 200 US elementary-school classrooms concludes that portable high-efficiency particulate air (HEPA) purifiers were linked with a modest reduction in respiratory virus diversity but not less viral exposure.

    For the study, published late last week in JAMA Network Open, a Boston Children’s Hospital–led research team examined data from the School Inner-City Asthma Intervention Study, which was conducted from September 2015 to June 2020 in 39 public schools in the Northeast. The goal was to determine whether HEPA filtration reduced asthma symptoms.

    Effectiveness depends on many factors

    The researchers randomly assigned classrooms in a 1:1 ratio to receive either four active HEPA purifiers (109 classrooms) or four identical filterless sham HEPA units (91). The team collected week-long bioaerosol samples three times during the school year and measured levels of 19 respiratory viruses using digital droplet polymerase chain reaction (ddPCR). 

    The primary outcome was high viral exposure (clustering of individual virus concentrations), and secondary outcomes were viral diversity (number of virus types) and individual virus levels. The median class size was 19 students, and the median grade was 3. Only 23.5% of classrooms had central heating, ventilation, and air-conditioning systems. 

    While HEPA purifiers are effective at reducing fine and coarse particulate matter, their effectiveness against viral aerosols and droplets in clinical settings is unclear, because it depends  on factors such as occupancy, ventilation, indoor climate, and occupant-specific characteristics such as age, the researchers said.

    “In addition, while low-cost sensors exist for some indoor pollutants, none exists for detection of viruses,” they wrote. “Some studies propose using carbon dioxide (CO2) as a surrogate marker for viral exposure; however, most research on built-environment factors and viral exposures is model-based, lacking comprehensive epidemiologic evidence.”

    Contribution of low relative humidity

    Viruses were detected in 98.5% of 532 bioaerosol samples (median, 3 viruses per classroom). The most common virus was rhinovirus (89.5% of samples), followed by respiratory syncytial virus (RSV) B (23.9%) and RSV A (12.4%), and influenza A and B (17.7% and 14.3%, respectively). 

    Air purifiers did not reduce overall viral load in classrooms, suggesting that additional interventions may be needed in schools.

    A total of 22.2% of air samples had higher average concentrations of most viruses, including coronavirus and influenza A. The use of HEPA purifiers wasn’t tied to lower odds of high viral exposure (odds ratio [OR], 0.50) but was associated with a 32.8% decrease in viral diversity. But reduced viral diversity wasn’t linked to fewer school absences. 

    Environmental risk factors for viral exposure were low relative humidity, lower grade in school, winter season, and higher levels of coarse particulate matter.

    “We found that air samples from classrooms included in our study had an average of three different respiratory viruses per classroom, with some having as many as 13, including pathogens capable of causing serious disease such as respiratory syncytial virus (RSV) and influenza virus,” corresponding author Peggy Lai, MD, MPH, of Massachusetts General Hospital, said in a Brigham and Women’s Hospital news release

    “Air purifiers did not reduce overall viral load in classrooms, suggesting that additional interventions may be needed in schools,” she added.

    Lai highlighted the association between lower humidity and high viral exposure, which suggests that controlling humidity may help lower exposure to certain viruses.

    “In addition to air filtration or better ventilation, maintaining classroom humidity between 40% and 60% may help lower viral exposures and improve comfort for students and teachers,” she said. “While our study did not find that HEPA air purifiers reduced high viral exposure in classrooms, it’s important to note that the trial was originally designed to measure other outcomes.”

    The authors called for more research into multicomponent environmental interventions such as those targeting higher relative humidity to lower respiratory virus exposure in schools.

    Continue Reading